Our lawyers and staff are focused on seeking exceptional results for our clients. We deliver value by creating solutions to legal problems through high quality work and innovative strategy designed to meet client objectives.
Select a practice area from the list below to view the results from that area.
Antitrust and Trade Regulation Selected Results
Representation of defendants UnitedHealth Group, Inc. and PacifiCare, Inc. in an antitrust lawsuit involving alleged price-fixing and fraud relating to prescription drug reimbursement under the federal Medicare Part D program. Plaintiff Omnicare sought damages exceeding $1 billion and permanent injunctive relief. After lengthy discovery and numerous pretrial motions, we obtained summary judgment in favor of our clients on all claims on January 16, 2009.
Counsel
|
|
|
Defense of predatory pricing case.
|
|
|
Dismissal of RICO class action brought in Miami, Florida against workers compensation insurers.
|
|
|
|
|
|
Appellate court dismissal of price-fixing class action against gasoline manufacturer.
|
|
|
Defense judgment in favor of Honeywell, dismissing tying and monopolization claims, affirmed by Sixth Circuit.
|
|
|
Obtained summary judgment dismissing an antitrust counterclaim to a patent infringement suit.
|
|
|
Obtained summary judgment in favor of its defendant client on various antitrust and common law claims involving the snowmobile racing industry.
|
|
|
Represented many large purchasers of bulk vitamins in “opt-out” actions challenging foreign cartel conduct. Obtained settlements several times the value of the recoveries by the class plaintiffs.
|
|
|
Representation of Blue Cross Blue Shield of Massachusetts, Blue Cross Blue Shield of Minnesota, and Federated Mutual Insurance Company in litigation before the federal District Court in the District of Columbia involving claims of state antitrust law violations regarding competitors' access to raw materials for Lorazepam and Clorazepate. The jury's verdict found that Mylan Laboratories Inc./Mylan Pharmaceuticals Inc., Cambrex Corporation, and Gyma Laboratories violated state antitrust laws and had restrained trade and acted willfully in excluding generic competitors' access. In post-trial motions, the District Court awarded Plaintiffs treble damages, for a total award to all plaintiffs of $76.8 million. The parties are currently awaiting the Court's order on prejudgment interest. Counsel
|
|
In May 1998, we reached an historic settlement in the State of Minnesota and Blue Cross and Blue Shield of Minnesota's lawsuit against the major cigarette manufacturers after 15 weeks of trial. The case was settled for $6.13 billion on behalf of the State of Minnesota and $469 million on behalf of Blue Cross and Blue Shield of Minnesota. The discovery obtained by the firm is being used by other states, private litigants and foreign countries.
Counsel
|
|
|
In defense of Section 5 antitrust allegations brought against Unocal based on reformulated gasoline patents. Initial decision granted November 25, 2003 in favor of Unocal.
|
|